{"meta":{"query_hash":"d371bb1ca0c1","filters":{"venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d371bb1ca0c1","api":"https://metacan.xera.ac/api/v1/cohort?venue=FARMAKOEKONOMIKA+Modern+Pharmacoeconomics+and+Pharmacoepidemiology"},"results":[{"id":"W2885933366","doi":"10.17749/2070-4909.2018.11.2.068-075","title":"Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review","year":2018,"lang":"en","type":"review","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Christian ministry; Military personnel; Healthcare system; Russian federation; Military health; Order (exchange); Political science; Business; Medicine; Finance; Law","score_opus":0.13930457714926184,"score_gpt":0.4827688397470621,"score_spread":0.3434642625978003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885933366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010251237,0.999121,0.00004265904,0.00030895864,0.000060425686,0.0000046858786,0.000014532762,0.0000015782289,0.00034367142],"genre_scores_gemma":[0.0008134913,0.9988863,0.00009171671,0.00011601622,0.000043954824,0.0000046462947,0.000013819,4.5400597e-7,0.000029662206],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99855167,0.000435442,0.0003480348,0.00016069571,0.0004113845,0.000092678594],"domain_scores_gemma":[0.99415946,0.004283452,0.0008165005,0.00006991943,0.0005495892,0.00012114071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002555149,0.0007077968,0.001196023,0.0056084036,0.00039754837,0.0019461215,0.00109452,0.0015090464,0.0027696022],"category_scores_gemma":[0.006934309,0.00036967188,0.0011823345,0.0073930454,0.0007019891,0.0019929486,0.0007807312,0.0010072318,0.0004305772],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069617556,0.00006238822,0.0011074672,0.18085146,0.00051073567,0.00022547548,0.00047536095,0.000669607,0.0002583157,0.009094755,0.022730261,0.78394455],"study_design_scores_gemma":[0.000029669818,0.00014077568,0.00513426,0.16714606,0.001100566,0.0015576467,0.00074068375,0.00022422252,0.00028646705,0.0023949868,0.8212016,0.000043018175],"about_ca_topic_score_codex":0.0049617975,"about_ca_topic_score_gemma":0.0082793385,"teacher_disagreement_score":0.0056084036,"about_ca_system_score_codex":0.0020961154,"about_ca_system_score_gemma":0.008528877,"threshold_uncertainty_score":0.015208483},"labels":[],"label_agreement":null},{"id":"W2921490086","doi":"10.17749/2070-4909.2018.11.4.073-080","title":"International experience in determining the cost-effectiveness thresholds","year":2019,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Geography; Value (mathematics); International comparisons; Quality-adjusted life year; Health technology; Willingness to pay; Health economics; Demography; Cost–benefit analysis; Socioeconomics; Economic growth; Political science; Health care; Economics; Sociology","score_opus":0.4557906184018746,"score_gpt":0.5288865026230042,"score_spread":0.07309588422112956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921490086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011629356,0.6687907,0.14309008,0.034151033,0.004294452,0.0014835396,0.0011728805,0.00021305282,0.135175],"genre_scores_gemma":[0.20545743,0.56408036,0.19644196,0.016460232,0.0043731686,0.004808328,0.0020430617,0.0007929875,0.0055424348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8650882,0.09227145,0.018189192,0.0053429836,0.017470576,0.0016376417],"domain_scores_gemma":[0.6610093,0.271936,0.015273699,0.011618988,0.037866324,0.0022957062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1886199,0.0022664065,0.002998939,0.009751172,0.0010217908,0.009655906,0.0036720117,0.0035802808,0.009156336],"category_scores_gemma":[0.3169812,0.0010111838,0.0036934796,0.012508356,0.0037601928,0.008212886,0.006372501,0.009661398,0.0015190078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007520141,0.00022085443,0.005204821,0.02639844,0.0015842102,0.00043283243,0.004507072,0.009467742,0.0007739228,0.20954296,0.019882428,0.7212327],"study_design_scores_gemma":[0.00030923812,0.000934654,0.013079658,0.12623091,0.00331151,0.0023387773,0.0040564206,0.0061325487,0.0049039056,0.1712066,0.6671361,0.00035971118],"about_ca_topic_score_codex":0.0037810542,"about_ca_topic_score_gemma":0.002950839,"teacher_disagreement_score":0.1886199,"about_ca_system_score_codex":0.009759975,"about_ca_system_score_gemma":0.01339561,"threshold_uncertainty_score":0.99752927},"labels":[],"label_agreement":null},{"id":"W2963337852","doi":"10.17749/2070-4909.2019.12.2.146-154","title":"Organizational structure and funding of health technology assessment agencies around the world","year":2019,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nice; Excellence; Agency (philosophy); Health technology; Government (linguistics); Organizational structure; Business; Health care; Public administration; Political science; Sociology","score_opus":0.2635332042692613,"score_gpt":0.4752818730011637,"score_spread":0.2117486687319024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963337852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43919,0.21316919,0.015582275,0.067607135,0.001490396,0.0012179894,0.01081662,0.0002763075,0.2506501],"genre_scores_gemma":[0.93842715,0.040031847,0.008572333,0.0015591246,0.0005357876,0.0005949106,0.0036570604,0.00006894982,0.0065528825],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97272587,0.014079343,0.0030815157,0.0015758952,0.005664435,0.0028730447],"domain_scores_gemma":[0.85427266,0.07826662,0.037114754,0.0039564725,0.019181276,0.0072082416],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017132916,0.0003796639,0.0004303029,0.013458256,0.0011188969,0.0063310484,0.0010702529,0.0012556877,0.007952231],"category_scores_gemma":[0.08235845,0.0004433695,0.00068671344,0.01526011,0.0015243908,0.0031696318,0.0028273237,0.0010181133,0.0008769342],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057818886,0.0003738344,0.18991601,0.008015561,0.0007964782,0.00071035576,0.004461436,0.0053778123,0.00067339756,0.12889805,0.03614713,0.62405175],"study_design_scores_gemma":[0.00030790264,0.00044652817,0.46021327,0.015611122,0.00069709774,0.001967321,0.010763652,0.0032291855,0.00080861204,0.021964535,0.48383474,0.00015592761],"about_ca_topic_score_codex":0.013165816,"about_ca_topic_score_gemma":0.008327872,"teacher_disagreement_score":0.98286706,"about_ca_system_score_codex":0.00848777,"about_ca_system_score_gemma":0.017534142,"threshold_uncertainty_score":0.09060866},"labels":[],"label_agreement":null},{"id":"W3098990825","doi":"10.17749/2070-4909/farmakoekonomika.2020.041","title":"Economic burden of systemic sclerosis: systematic review","year":2020,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Systematic review; Cochrane Library; MEDLINE; Quality of life (healthcare); Burden of disease; Disease burden; Disease; Meta-analysis; Pathology","score_opus":0.060521842503713674,"score_gpt":0.32999750393738136,"score_spread":0.2694756614336677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098990825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019234081,0.9950014,0.00016720536,0.00048943644,0.00013065305,0.0004399323,0.0013146221,0.000014062382,0.00051931775],"genre_scores_gemma":[0.03338298,0.9638098,0.00062693836,0.0005128749,0.00009472793,0.00081347465,0.00060187513,0.000008968759,0.00014844569],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9892336,0.004360854,0.0033674084,0.0006389213,0.0020594688,0.00033977785],"domain_scores_gemma":[0.96271914,0.02661671,0.0074160746,0.00043436827,0.00250759,0.00030607518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009928171,0.0017822388,0.010399816,0.012836129,0.00059301086,0.0030284426,0.0017505534,0.0016484964,0.006371025],"category_scores_gemma":[0.05287186,0.0012220675,0.007864319,0.014885275,0.00093657407,0.0023090732,0.0018415573,0.0013011959,0.00029311478],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014911089,0.00000799221,0.00096188334,0.97014993,0.01462974,0.000093411276,0.00007825867,0.00013571366,0.00003535481,0.00023000252,0.0011953405,0.012333218],"study_design_scores_gemma":[0.00039091977,0.0001432293,0.0066405553,0.8816163,0.097209156,0.00043621525,0.0002485303,0.00018707989,0.000113762675,0.0006151425,0.012359107,0.000039942723],"about_ca_topic_score_codex":0.008689793,"about_ca_topic_score_gemma":0.017831685,"teacher_disagreement_score":0.012836129,"about_ca_system_score_codex":0.0055867555,"about_ca_system_score_gemma":0.012427173,"threshold_uncertainty_score":0.05250579},"labels":[],"label_agreement":null},{"id":"W3207420083","doi":"10.17749/2070-4909/farmakoekonomika.2021.062","title":"History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization","year":2021,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Randomization; Emperor; Theme (computing); Clinical trial; Medicine; History; Genealogy; Computer science; Surgery; Ancient history; Pathology","score_opus":0.2538322693677518,"score_gpt":0.49238707006139437,"score_spread":0.2385548006936426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207420083","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042878857,0.7001946,0.021192694,0.18710168,0.072445564,0.0010215093,0.0014700542,0.0003898379,0.015755294],"genre_scores_gemma":[0.018300314,0.66454387,0.051261064,0.1765017,0.06773568,0.0056455303,0.0022019953,0.0010410819,0.012768753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7040521,0.18760113,0.034205656,0.015270153,0.05655383,0.002317187],"domain_scores_gemma":[0.37824544,0.4878873,0.027149396,0.0361455,0.06668339,0.003888992],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.20247033,0.0016175483,0.0046042083,0.0096435975,0.0022889257,0.017663088,0.003767489,0.01061987,0.0108353775],"category_scores_gemma":[0.44591376,0.002079468,0.002868559,0.014185624,0.015689762,0.017840624,0.005513649,0.015148355,0.007835378],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047794488,0.00006559661,0.00066906115,0.039394774,0.00062511116,0.00010891792,0.0020669482,0.00034533837,0.00043423192,0.21900031,0.44034198,0.2964698],"study_design_scores_gemma":[0.00016553179,0.00020295118,0.0007095541,0.036690988,0.0003528588,0.0003106114,0.00039050833,0.00015969902,0.00052500295,0.06552196,0.89487755,0.00009274067],"about_ca_topic_score_codex":0.002999796,"about_ca_topic_score_gemma":0.0022779896,"teacher_disagreement_score":0.99771106,"about_ca_system_score_codex":0.014815228,"about_ca_system_score_gemma":0.023540083,"threshold_uncertainty_score":0.98349607},"labels":[],"label_agreement":null},{"id":"W4224020286","doi":"10.17749/2070-4909/farmakoekonomika.2022.107","title":"The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies","year":2022,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical Practice; Quarter (Canadian coin); Economic evaluation; Russian federation; Quality (philosophy); Actuarial science; Accounting; Family medicine; Business; Pathology","score_opus":0.277111289096794,"score_gpt":0.5229341812689959,"score_spread":0.24582289217220193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224020286","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24815112,0.5306375,0.059647646,0.052271802,0.0029546493,0.01648367,0.02885592,0.00024951712,0.06074826],"genre_scores_gemma":[0.8595347,0.06465374,0.053950515,0.005242052,0.0015789062,0.008382242,0.005445297,0.00006991605,0.0011426503],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.51806647,0.39050987,0.04365116,0.009295548,0.035749055,0.0027279332],"domain_scores_gemma":[0.283052,0.5154487,0.1066383,0.035798747,0.055720717,0.0033416236],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2969014,0.0006612827,0.0021574148,0.008874823,0.0009156003,0.0070618796,0.0024649573,0.0025534579,0.0036591685],"category_scores_gemma":[0.3563907,0.00057974627,0.0021843964,0.011496487,0.0026078904,0.0029964608,0.0022095994,0.0013252092,0.00054664107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077119917,0.0007621577,0.2506849,0.10690491,0.008854495,0.0008923916,0.0023497322,0.010364287,0.0029683844,0.037892886,0.02210055,0.54851323],"study_design_scores_gemma":[0.0032406321,0.0065112337,0.54492456,0.12513907,0.011743506,0.002846379,0.004002007,0.012023705,0.010932321,0.023785722,0.25440228,0.00044863843],"about_ca_topic_score_codex":0.0037033802,"about_ca_topic_score_gemma":0.0035748242,"teacher_disagreement_score":0.2969014,"about_ca_system_score_codex":0.006356155,"about_ca_system_score_gemma":0.026974337,"threshold_uncertainty_score":0.86704576},"labels":[],"label_agreement":null},{"id":"W4399124907","doi":"10.17749/2070-4909/farmakoekonomika.2024.246","title":"Mathematical modeling and analysis of export trends for certain pharmaceutical groups","year":2024,"lang":"en","type":"article","venue":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","topic":"Global Trade and Competitiveness","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Econometrics; Computer science; Business; Mathematics","score_opus":0.07493252648543272,"score_gpt":0.35389921259802315,"score_spread":0.27896668611259046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399124907","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08718421,0.0014611165,0.8851736,0.001353467,0.00015937605,0.00013431154,0.0020960118,0.00059246056,0.02184547],"genre_scores_gemma":[0.86813426,0.0029966368,0.09236128,0.0002275838,0.00020702167,0.0008005448,0.0022272037,0.0003262625,0.032719232],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995153,0.00011742959,0.00003550806,0.00013341561,0.00013000032,0.00006835212],"domain_scores_gemma":[0.9983045,0.000955584,0.00034707406,0.00007889724,0.00028223003,0.000031691314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001303351,0.0008683048,0.00074390386,0.0017284456,0.00037269166,0.0011393538,0.0013303485,0.0010817122,0.004793454],"category_scores_gemma":[0.004300954,0.00036720358,0.001920066,0.0013254598,0.00064962823,0.0015140524,0.0006389545,0.0010485812,0.0011096436],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004064489,0.000058571353,0.0046094437,0.0002642626,0.00007159502,0.00022417135,0.00021861639,0.8994789,0.002725163,0.07407665,0.0018653981,0.016366525],"study_design_scores_gemma":[0.0000036952833,0.00001973036,0.0006150785,0.000012484184,0.000018157383,0.000046565736,0.000017567048,0.9895325,0.00038900247,0.0072476347,0.0020890313,0.000008471375],"about_ca_topic_score_codex":0.006269112,"about_ca_topic_score_gemma":0.0024155935,"teacher_disagreement_score":0.006269112,"about_ca_system_score_codex":0.0011645223,"about_ca_system_score_gemma":0.0010481811,"threshold_uncertainty_score":0.016035736},"labels":[],"label_agreement":null}]}